Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in Pediatric Subjects With Childhood Epilepsy
NCT04015141Phase 2Active, not recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2019
- Primary completion
- Apr 2027
- Modality
- Classical Binding Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of perampanel in epilepsy, focal onset seizure, sponsored by Eisai Co., Ltd.. Started May 2019; status: active, not recruiting.
02
Drugs
perampanel
03
Conditions
epilepsyfocal onset seizure
Beyond the preview
Go deeper on NCT04015141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04015141.